The Board of Directors of Nukute Oy has announced an appointment of Matti E. Lehtonen as a CEO of Nukute Oy starting on February 1st, 2022.
Matti brings to Nukute a wealth of experience in medical technology and building and managing businesses and organisations with global reach. Matti joins the company after 14 years with GE Healthcare where he served as the General Manager of GE’s global Anesthesia and Respiratory Care business, and from 2016 also as the Chairman of the Board of GE Healthcare Finland. Prior to GE, Matti worked in a variety of leadership positions in healthcare, wellness, electronics manufacturing and renewable energy, covering the whole value chain from technology and product development to manufacturing to sales and marketing.
A native of Finland, Matti has spent over 30 years of his career in China and speaks eight languages, including Chinese, French, and Portuguese. Matti holds a MSc degree in Computer Science and Manufacturing Management from Helsinki University of Technology (now Aalto University) and he studied at Peking University, Department of Chinese Language and Literature, majoring in modern Chinese grammar. In his free time, Matti is a passionate baroque musician and an avid juggler.
Sleep apnea is a major global health challenge, affecting up to 1 billion people, that today goes mostly undiagnosed. Nukute’s solution is perfect for convenient and cost-effective analysis of the severity of the condition, the first step in providing the right therapy. Furthermore, going forward, Nukute’s unique technology can be applied to the detection of a variety of other respiratory conditions. With my long history in Respiratory Care, the lung has always been close to my heart, and I am thrilled to join Nukute at this exciting stage on its growth path,’ commented Matti E. Lehtonen.
Please join us in welcoming Matti to Nukute. We look forward to him spearheading the next fundraising round, and accelerating Nukute´s commercial success,’ said Timo Hildén, Chairman of the Board of Directors.